INanoBio Revenue and Competitors
Estimated Revenue & Valuation
- INanoBio's estimated annual revenue is currently $1.9M per year.
- INanoBio's estimated revenue per employee is $129,280
Employee Data
- INanoBio has 15 Employees.
- INanoBio grew their employee count by -6% last year.
INanoBio's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Director, Device Development | Reveal Email/Phone |
2 | Finance and Operations Manager | Reveal Email/Phone |
3 | Senior Research Scientist | Reveal Email/Phone |
4 | Senior Fabrication Engineer | Reveal Email/Phone |
INanoBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.6M | 51 | 11% | N/A | N/A |
#2 | N/A | 54 | 26% | N/A | N/A |
#3 | $0.9M | 10 | 11% | N/A | N/A |
#4 | $9.6M | 53 | N/A | N/A | N/A |
#5 | $0.8M | 8 | 0% | N/A | N/A |
#6 | $0.5M | 5 | 0% | N/A | N/A |
#7 | $0.4M | 4 | 0% | N/A | N/A |
#8 | $1.8M | 17 | 13% | N/A | N/A |
#9 | $0.6M | 6 | 0% | N/A | N/A |
#10 | $1.3M | 14 | 27% | N/A | N/A |
What Is INanoBio?
INanoBio's mission is to develop high-accuracy early stage disease diagnostics using transformative nano-biotechnology platforms and machine learning. Extract systems scale information from complex disease biology, identify and detect disease specific molecular biomarkers, signatures at prodromal or pre-symptomatic stages. We believe most diseases can be detected early, enabling early personalized therapeutic intervention to preempt full development of diseases, ushering in preemptive medicine.
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.9M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 15 | 36% | N/A |
#2 | N/A | 15 | 0% | N/A |
#3 | $1.8M | 15 | -6% | N/A |
#4 | $4.5M | 15 | 0% | N/A |
#5 | $1.6M | 15 | -12% | N/A |